Panupong Mahalapbutr
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Corrigendum to "Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies" [Int. J. Biol. Macromol. Volume 260 (2024), 129308].
Journal: International journal of biological macromolecules
Published: July 15, 2026
Anilino-1,4-naphthoquinone derivatives exhibit antiproliferative, anti-inflammatory, and pro-apoptotic activities in LPS-stimulated SW480 colorectal cancer cells: In vitro and in silico studies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 09, 2026
Structural Dynamics and Susceptibility of Aminonaphthoquinone-Chalcone Hybrids Against Human Tyrosinase.
Journal: International journal of molecular sciences
Published: April 08, 2026
Molecular Dynamics and Solvated Interaction Energy Prioritize Cannabidiol and Cannabinol as Variant-Spanning SARS-CoV-2 RBD-ACE2 Interface Blockers.
Journal: Molecules (Basel, Switzerland)
Published: January 13, 2026
Aromatase inhibitory, anti-proliferative, and apoptosis-inducing effects of naphthoquinone-triazole derivatives for potential anti-breast cancer agents: In vitro and molecular docking studies.
Journal: Biochemical and biophysical research communications
Published: December 19, 2025
Identification of Sulfonamide-Vinyl Sulfone/Chalcone and Berberine-Cinnamic Acid Hybrids as Potent DENV and ZIKV NS2B/NS3 Allosteric Inhibitors.
Journal: International journal of molecular sciences
Published: November 20, 2025
Detection of Serum Tumor-Associated Glycobiomarker for Meningioma Using Dolichos biflorus Agglutinin.
Journal: Journal of proteome research
Published: November 18, 2025
Asiatic Acid from Centella asiatica as a Potent EGFR Tyrosine Kinase Inhibitor with Anticancer Activity in NSCLC Cells Harboring Wild-Type and T790M-Mutated EGFR.
Journal: Biomolecules
Published: August 14, 2025
Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 25, 2025
Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinoma.
Journal: Biomedical reports
Published: June 17, 2025
Correction: Suriya et al. Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. Pharmaceutics 2022, 14, 1461.
Journal: Pharmaceutics
Published: February 27, 2025
Last Updated: 09/26/2026